Immune-modulating Effect of Korean Red Ginseng by Balancing the Ratio of Peripheral T Lymphocytes in Bile Duct or Pancreatic Cancer Patients With Adjuvant Chemotherapy.
- 2021
- RCT
- In vivo (Athens, Greece) 35(3)
- Im-Kyung Kim
- Kang Young Lee
- Jeonghyun Kang
- Joon Seong Park
- Joon Jeong
- PubMed: 33910879
- DOI: 10.21873/invivo.12454
- High evidence
- Clinical
After chemotherapy, the percentage of CD4+ T lymphocytes was significantly higher in the ginseng group than in the control group (42.01% vs. 33.69%, p=0.048).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- daily (dose not specified in abstract)